Literature DB >> 8457531

A trial of zinc supplementation in young rural Gambian children.

C J Bates1, P H Evans, M Dardenne, A Prentice, P G Lunn, C A Northrop-Clewes, S Hoare, T J Cole, S J Horan, S C Longman.   

Abstract

The present study tested the hypothesis that inadequate Zn intake might be responsible for failure to thrive and impaired catch-up growth in young rural Gambian children, and that Zn supplements might be beneficial. Gambian children might be deprived of Zn because of its poor availability from their predominantly plant-based diet. Rural Gambian children (110; fifty boys, sixty girls) aged between 0.57 and 2.30 years were divided into two matched groups, one to receive 70 mg Zn twice weekly for 1.25 years, and the other a placebo. Growth and mid-upper-arm circumference were measured at weekly intervals throughout the study and illnesses were monitored. Capillary blood and urine samples were collected at 0, 2 and 8 weeks. Body weights and arm circumferences showed a linear increase, plus a seasonal effect (rainy season faltering). For body weight there was no significant overall effect of the supplement. For arm circumference, a very small (2%) but significant (P < 0.01) difference favoured the supplemented group. Plasma thymulin was much lower at the first clinic than at the second and third clinics, and in vitro Zn stimulation was greater at the first clinic. There was, however, no effect of Zn in vivo. Likewise, Zn did not significantly benefit T-cell numbers or ratios, secretory IgA in urine, circulating hormone levels or biochemical indices of Zn status. One index of intestinal permeability, i.e. lactulose: creatinine, was improved (P < 0.02) by the supplement, but the lactulose: mannitol value was not; this requires further investigation. Dietary Zn deficiency is, thus, unlikely to be of major overall importance for rural Gambian children's ability to thrive, and blanket Zn supplementation is not justified. There may, however, be vulnerable sub-groups who would benefit from Zn supplements.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Anthropometry; Biology; Child Development; Clinical Research; Clinical Trials; Demographic Factors; Developing Countries; Double-blind Studies; English Speaking Africa; Examinations And Diagnoses; Gambia; Growth; Hematological Effects; Hemic System; Infant; Ingredients And Chemicals; Inorganic Chemicals; Laboratory Examinations And Diagnoses; Measurement; Metals; Physiology; Population; Population Characteristics; Research Methodology; Rural Population; Serum Zinc Level--analysis; Studies; Western Africa; Youth; Zinc--administraction and dosage

Mesh:

Substances:

Year:  1993        PMID: 8457531     DOI: 10.1079/bjn19930026

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  33 in total

1.  Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.

Authors:  Marianna K Baum; Shenghan Lai; Sabrina Sales; J Bryan Page; Adriana Campa
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled trial.

Authors:  O Müller; H Becher; A B van Zweeden; Y Ye; D A Diallo; A T Konate; A Gbangou; B Kouyate; M Garenne
Journal:  BMJ       Date:  2001-06-30

3.  Serum zinc levels in hospitalized children with acute lower respiratory infections in the north-central region of Nigeria.

Authors:  Rasheedat Mobolaji Ibraheem; AbdulWahab Babatunde Rotimi Johnson; Aishatu Ahmed Abdulkarim; Sikiru A Biliaminu
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 4.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

5.  In vitro mineral binding capacity of five fiber sources and their insoluble components for copper and zinc.

Authors:  S S Claye; A Idouraine; C W Weber
Journal:  Plant Foods Hum Nutr       Date:  1996-06       Impact factor: 3.921

6.  Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.

Authors:  Zohra S Lassi; Jaameeta Kurji; Cristieli Sérgio de Oliveira; Anoosh Moin; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2020-04-08

Review 7.  Interactions between zinc deficiency and environmental enteropathy in developing countries.

Authors:  Greta W Lindenmayer; Rebecca J Stoltzfus; Andrew J Prendergast
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

8.  Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.

Authors:  K Ryan Wessells; Sonja Y Hess; Noel Rouamba; Zinewendé P Ouédraogo; Mark Kellogg; Rie Goto; Christopher Duggan; Jean-Bosco Ouédraogo; Kenneth H Brown
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

9.  Excess bioavailability of zinc may cause obesity in humans.

Authors:  S K Taneja; M Mahajan; P Arya
Journal:  Experientia       Date:  1996-01-16

Review 10.  Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease.

Authors:  Charles P Larson; S K Roy; Azharul Islam Khan; Ahmed Shafiqur Rahman; Firdausi Qadri
Journal:  J Health Popul Nutr       Date:  2008-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.